Skip to main content

Christopher R Piszczatoski, PharmD, BCPS

Pharmacist

Photo of Christopher R Piszczatoski

Research at a glance

Top areas of exploration

  • Hypertension , 2 publications
  • Osteoarthritis , 2 publications
  • Antihypertensive Agents , 2 publications
  • COVID-19 , 2 publications

Research activity

11 publications

123 citations

Why is this important?

My publications

11 publications

2024

The "Weight" for a New Agent Is Almost Over: A Commentary on the Novel Triagonist Retatrutide for Obesity.

The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians

PubMed Publisher's site

2022

Pharmacological considerations when treating hypertensive patients for osteoarthritis.

Expert opinion on pharmacotherapy

PubMed Publisher's site

2022

Finally, an FDA Approval for an Immunization Against COVID-19: Hope on the Horizon.

The Annals of pharmacotherapy

PubMed Publisher's site

2022

Orladeyo (Berotralstat): A Novel Oral Therapy for the Prevention of Hereditary Angioedema.

The Annals of pharmacotherapy

PubMed Publisher's site

2021

Topical Clascoterone: The First Novel Agent for Acne Vulgaris in 40 Years.

Clinical therapeutics

PubMed Publisher's site